Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type natriuretic peptide, which is normally produced by the ventricular myocardium.
Nesiritide, a recombinant human B-type natriuretic peptide, is the first in a new drug class for the treatment of decompensated heart failure. The drug binds to ...
Learn about Natrecor (Nesiritide) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
CAPITALS indicate life-threatening, underlines indicate most frequent. Strikethrough. Discontinued. 1. High Alert nesiritide (ne-sir-i-tide). Natrecor. Classification.
Easy to read patient leaflet for Nesiritide. Includes indications, proper use, special instructions, precautions, and possible side effects.
Medscape - Indication-specific dosing for Natrecor (nesiritide), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...
Jun 13, 2016 ... Nesiritide (recombinant human brain natriuretic peptide, BNP 1-32) is a vasodilator that has undergone clinical trials in patients with acute HF.
Oct 21, 2007 ... Nesiritide is a medication used to treat acutely decompensated congestive heart failure with dyspnea at rest or with minimal exertion (such as ...
NATRECOR (Nesiritide) drug information & product resources from MPR including dosage information, educational materials, & patient assistance.